MedPath

CoolSculpting the Flanks

Not Applicable
Conditions
Body Fat Disorder
Interventions
Device: The ZELTIQ System
Registration Number
NCT03304925
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flanks.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
320
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fat ReductionThe ZELTIQ SystemThe treatments are designed to see if the fat can be reduced in the flanks with a new applicator design.
Primary Outcome Measures
NameTimeMethod
Effectiveness endpoint gauged by reduction in fat layer thicknessFinal post-treatment visit

Reduction in fat layer thickness as measured by ultrasound at the final post-treatment visit.

Safety endpoint in relation to adverse eventsFinal post treatment visit

Measurement of device- or procedure-related adverse events. It is expected there will be zero UADEs

Secondary Outcome Measures
NameTimeMethod
Subject surveyFinal post-treatment visit

Subject survey as assessed by questionnaire administered at the final post-treatment visit.

Photo reviewFinal post-treatment visit

Correct identification of pre-treatment vs. final post-treatment visit images by two out of three blinded independent reviewers.

Trial Locations

Locations (7)

Zel Skin & Laser Specialist

🇺🇸

Edina, Minnesota, United States

Innovation Research Center

🇺🇸

Pleasanton, California, United States

Laser & Skin Surgery Center of Northern California

🇺🇸

Sacramento, California, United States

SkinCare Physicians of Chestnut Hill

🇺🇸

Chestnut Hill, Massachusetts, United States

Laser & Skin Surgery Center of New York

🇺🇸

New York, New York, United States

EpiCenter Skincare and Laser Center

🇺🇸

Dallas, Texas, United States

Brian S. Biesman, MD

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath